Cyclopentanecarboxylic acid → Cyclopentanecarboxylic acid [2-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridin-7-yl]-amide

HRID 731647

Reaktionsgleichung

Reaktionsgleichung von HRID 731647
[CH3:1][C:2]1[O:6][N:5]=[C:4]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)[C:3]=1[C:13]1[N:14]=[C:15]2[CH:20]=[C:19]([NH2:21])[CH:18]=[CH:17][N:16]2[CH:22]=1.[CH:23]1([C:28](O)=[O:29])[CH2:27][CH2:26][CH2:25][CH2:24]1>>[CH3:1][C:2]1[O:6][N:5]=[C:4]([C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][CH:12]=2)[C:3]=1[C:13]1[N:14]=[C:15]2[CH:20]=[C:19]([NH:21][C:28]([CH:23]3[CH2:27][CH2:26][CH2:25][CH2:24]3)=[O:29])[CH:18]=[CH:17][N:16]2[CH:22]=1

Komponenten

3

Versuchsvorschrift

As described for Example 47, 2-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridin-7-ylamine (92 mg, 0.32 mmol) was converted, using cyclopentanecarboxylic acid instead of 3-pyridylacetic acid, to the title compound (11.1 mg, 10%) which was obtained as an off-white solid. MS: m/e=387.1 [M+H]+.

Quellen und Nachweise

ORD-Eintrag
ord-381ff34f55c84abbae69aa734dff3d1f
Quelldatensatz
uspto-grants-2009_09
Patentnummer
US07585874B2

Verknüpfte Notizen

Wird geladen…